Drug-induced colitis in adults: A systematic review  by Chean, C.S. et al.
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resources may be related to outcomes.http://dx.doi.org/10.1016/j.ijsu.2016.08.146
0408: RETROSPECTIVE COMPARISON OF THE OUTCOMES OF EXTRALE-
VATOR ABDOMINOPERINEAL EXCISION (ELAPE) WITH ABDOMINOPER-
INEAL RESECTION (APR) FOR RECTAL CANCER
M. Alkhusheh, A. Mahmoud*, A. Ney, P. Olaniyi, M. Lamah. royal sussex
county hospital, Brighton, UK.
Aim: Specimen quality as a risk factor for local rectal cancer recurrence,
was compared between tissue specimens obtained using the Extralevator
abdominoperineal excision (ELAPE) approach and conventional abdomi-
noperineal resection approach in a retrospective analysis.
Method: Specimen quality in 67 surgical resection specimens of rectal
tumours was compared using histopathology reports. 39 resections were
preformed using the Extralevator abdominoperineal excision approach
and 28 using conventional abdominoperineal resection. The Quirke clas-
siﬁcation used in the dutch TME trial was used to characterize specimen
quality. Plane of excision, presence of specimen wasting, as well as tissue
defects and the presence of intraoperative bowel perforation were classi-
ﬁed into three categories: complete, nearly complete and incomplete
resection.
Result: In the ELAPE group ;16 (41% ) specimens were reported as com-
plete excision, 18 (46.2 % ) as nearly complete, 5 (12.8 %) as incomplete.
Amongst the conventional APR group: 15 (53.6%) classiﬁed as complete
excision, 12(42.9 %) as nearly complete, and 1 specimen (3.6 %) as
incomplete.
Conclusion: In this study, lower specimen quality was demonstrated in
the ELAPE group than in the APR group. further assessment of disease
recurrence in these patients would be beneﬁcial to demonstrate the
impact of this risk factor on disease recurrence.http://dx.doi.org/10.1016/j.ijsu.2016.08.147
0426: DIAGNOSTIC BIOPSIES FOR PERSISTENT DIARRHOEA
Z. Sher 1,*, G. Sisson 2. 1 South Thames Foundation School, London, UK; 2Darent
Valley Hospital, Kent, UK.
Aim: To determine if biopsies are taken in all patients undergoing colo-
noscopy due to persistent diarrhoea, as per quality standards set by the
Joint Advisory Group on Gastrointestinal Endoscopy, for prompt diagnosis
and management of malignancy/inﬂammatory bowel disease.
Method: A retrospective analysis of colonoscopy and histology reports of
50 patients referred for persistent diarrhoea was carried out. The initial
audit showed an 88% rate of biopsy (n ¼ 121).
Result: After recommendations to improve the rate of biopsy were
implemented, the number of biopsies taken improved to 96% (n ¼ 50), an
overall 8% increase in the total number of biopsies taken six months after
the initial audit. 54% of the biopsies were normal. 12% showed tubular
adenoma, and 6% detected Crohns disease, 4% each detected collagenous
colitis, ischaemic colitis and proctitis. The rate of ulcerative colitis, focal
active colitis, lymphocytic colitis and active ileitis was 2%. Only 4% of
colonoscopies were not biopsied- the rate of failure to biopsy did not differ
between medical or surgical operator.
Conclusion A complete audit cycle identiﬁed the need to improve the
biopsy rate in diagnostic colonoscopies, and demonstrated a signiﬁcant
improvement in the number of biopsies taken by the time of re-audit.http://dx.doi.org/10.1016/j.ijsu.2016.08.148
0510: SENSITIVITY OF ROUTINE CT ABDOMEN AND PELVIS FOR DETECT-
ING COLORECTAL CONCERK. Myo*, V. Manda, L.J. Qi, D. Rawlings, E. Leung. Croshouse Hospital,
Ayrshire and Arran NHS, West of Scotland, UK.
Aim: We have little data about the sensitivity of routine CT abdomen and
pelvis (RCTAP) in detecting colorectal cancer. Therefore, a retrospective
study was performed to determine the sensitivity of RCTAP in identifying
the malignant lesion in our already diagnosed colorectal cancer patients.
Method: Prospectively collected data for all colorectal cancer patients in
the Ayrshire and Arran Health Board were examined from January 2010 to
December 2014. The correlation between their preoperative CT ﬁndings
and the ﬁnal histopathological reports of their resected specimens was
analyzed.
Result: The total of 882 patients were collected for the 5-year period. 165
patients were excluded. The overall sensitivity of RCTAP for colorectal
cancer was 74.5 and the sensitivity improves as the lesion gets bigger: 50%
 2 cm, 65% >2 and 3 cm, 75% for >3 and  4 cm, 86% >4 and  5 cm and
95% > 5 cm. In terms of Duke's stage disease, the sensitivity of detecting
the lesion was 52% in Duke's A, 82% Duke's B, and 80% Duke's C.
Conclusion: RCTAP appears to have a poor sensitivity of cancer detection
for small and early Duke's A lesions, but the sensitivity seems to improve
signiﬁcantly with bigger and more advanced lesion.http://dx.doi.org/10.1016/j.ijsu.2016.08.149
0526: ENHANCED RECOVERY AFTER SURGERY VERSUS CONVENTIONAL
CARE IN ELECTIVE COLONIC AND RECTAL CANCER SURGERY: FIRST
EXPERIENCE IN SAUDI ARABIA
K. ElGendy*, A. Privitera, K. Sabr, A. AlNaamy, A. Salem. King Fahad
Specialist Hospital, Dammam, Saudi Arabia.
Aim: To compare outcomes of conventional perioperative care with ERAS
care pathway including elective colorectal cancer surgery patients for ﬁrst
time in a single centre in Saudi Arabia.
Method: Cohort study, comparing two groups, each group being managed
by one consultant's team. Outcome measures included: hospital stay,
postoperative complications, 30 days morbidity & mortality, 6 month
follow up and return to normal ambulation, bowel motion & normal diet.
Result: 32 patients were included for each group with comparable base-
line features (age,sex,BMI,ASA). Rectal surgeries represented 32% of ERAS
group and 53% of conventional group. 80% of each group had PCA while
remaining had epidural postoperatively. There was highly signiﬁcant
different regarding length of hospital stay (5.83 versus 9 days, p < .001)
and return to normal diet (2.9 vs 3.9, p ¼ 0.01). There was no signiﬁcant
difference in postoperative complications, 30 days morbidity or 6 months
FU. Subgroup analysis of rectal surgery patients revealed shorter hospital
stay in ERAS group (7.36 vs 8.3, p ¼ 0.25), however, longer than colonic
surgery in either groups.
Conclusion: ERAS pathway provided shorted hospital stays without
increased morbidity or mortality. Differences were less pronounced in
rectal surgery subgroup which might beneﬁt of further research regarding
ERAS pathways in rectal surgery.http://dx.doi.org/10.1016/j.ijsu.2016.08.150
0528: DRUG-INDUCED COLITIS IN ADULTS: A SYSTEMATIC REVIEW
C.S. Chean 1,*, A. Ahmed 1, B. Michael 2. 1University of Liverpool, Liverpool,
Merseyside, UK; 2Royal Liverpool University Hospital, Liverpool, Merseyside,
UK.
Aim: Drug-induced colitis is increasingly common and remains a diag-
nostic challenge. This review aims to outline the characteristic endoscopic
and histologic features of main types of drug-induced colitides and to
distinguish them from inﬂammatory bowel disease (IBD), with which they
share similar clinical presentations.
Method: A systematic MEDLINE search was performed, yielding 472 ar-
ticles. Articles on pseudomembranous colitis were excluded. 113 articles
were eligible for ﬁnal review.
Abstracts / International Journal of Surgery 36 (2016) S31eS132 S61Result: Microscopic, NSAIDs-induced and ischemic colitis were the main
drug-induced colitides. Microscopic colitis, which included collagenous
and lymphocytic colitis, was usually caused by proton-pump inhibitors
and non-steroidal anti-inﬂammatory drugs (NSAIDs). Endoscopic ﬁndings
were often unremarkable, however histology classically revealed marked
lymphocytosis (lymphocytic colitis) and thickening of the sub-epithelial
collagen layer (collagenous colitis). Use of anti-hypertensives, statins, ergot
alkaloids, and oral contraceptives were associated with ischemic colitis.
Colonoscopy revealed severe mucosal erythema and oedema with multi-
ple non-transmural focal ulcerations. Histologically, diffuse mucosal
ischaemic injury was seen, without granulomas or lymphoid inﬁltration.
Other drug-induced colitides such as eosinophilic, immune-mediated and
DRESS-induced colitis, were also discussed.
Conclusion: Drug-induced colitis represents a diagnostic challenge and
may occur concomitantly with IBD. Endoscopy and histology remain the
investigation of choice. Drug-induced colitis should be considered in
symptomatic patients taking known offending drugs, especially NSAIDs.http://dx.doi.org/10.1016/j.ijsu.2016.08.151
0536: POSTOPERATIVE COLONOSCOPY FOLLOW UP FOR PATIENTS
WITH CROHN'S DISEASE
M. Jitsumura*, T. Davies, D. Harris. Colorectal Department, Singleton Hospital,
Abertawe Bro Morgannwg, University Health Board, UK.
Introduction:Many patients with Crohn's disease who undergo intestinal
resection will suffer from peri-anastomotic recurrence. The European
Crohn's and Colitis Organisation guidance (2013) recommends ileo-colo-
noscopy within the ﬁrst year of surgery to establish treatment for pre-
vention of recurrence disease. This study was conducted to monitor
whether post-operative Crohn's patients have been managed appropri-
ately in our unit.
Method: 93 patients with Crohn's disease who underwent ileocolic
resection from 2010 to 2014 were studied retrospectively.
Result: 29 patients (31.2%) underwent postoperative colonoscopy, of
which 16 (17.2%) were as a routine follow-up and 6 patients (6.5%) had it
within one year. Recurrent disease was detected in 50% of patients after
routine colonoscopy. In the 5-year study period, 19 patients (65.5%) had
endoscopic recurrence and 12 (13%) patients had required further surgery.
Medical treatment was either initiated or upgraded in only 57.9% of pa-
tients with recurrent disease detected after endoscopy. No patients
compliant with endoscopic surveillance required further surgery.
Conclusion: This study highlighted poor compliance with the guideline,
which is multi-factorial including a lack of awareness amongst clinicians
and resource issues. This study has a number of limitations. Nonetheless, it
suggests the importance of a tailored treatment in a timely manner with
pre-emptive colonoscopic surveillance.http://dx.doi.org/10.1016/j.ijsu.2016.08.152
0548: REDUCING ADMISSIONS IN PATIENTS PRESENTING WITH RECTAL
BLEEDING
R. Law*, J. Mok, P. Jordan, P. Medland, I. Swift. Croydon University Hospital,
London, UK.
Aim: Most patients presenting with fresh rectal bleeding require no
intervention acutely. We aim to develop an admission algorithm to safely
manage patients with rectal bleeding, with a view to reducing hospital
stay.
Method: A retrospective study of 92 patients admitted with rectal
bleeding was performed. Admission observations and investigations were
recorded and an algorithm was developed. This was applied to the study
group and the number of potentially avoidable admissions was recorded.
Result: We recorded the admission systolic blood pressure, haemoglobin
and anticoagulation status. Ninetytwo patients presented with rectal
bleeding, of those 62 were admitted. Among those admitted, we applied
the algorithm and identiﬁed a further 21 who could have been dischargedwith ‘hot clinic’ follow up. Overall the percentage of admissions for pa-
tients presenting with rectal bleeding could have been reduced from 67%
to 45%.
Conclusion: The application of this algorithm for rectal bleeding could
safely avoid unnecessary admissions. Further studies are required to vali-
date the algorithm using a larger prospective cohort in patients presenting
with rectal bleeding.http://dx.doi.org/10.1016/j.ijsu.2016.08.153
0632: WHAT HAPPENS TO THE FOLLOW-UP OF PATIENTS WHO UN-
DERGO INCISION AND DRAINAGE FOR PERIANAL ABSCESS?
S.J. Parton*, M. Lee, A. Harikrishnan. Shefﬁeld Teaching Hospitals, Shefﬁeld,
UK.
Aim: To conduct a temporal audit in to the follow-up of patients who
undergo incision and drainage (I&D) for perianal abscess.
Method: Patients undergoing I&D of perianal abscess between January
2014 and June 2014, and those requiring a 2nd I&D, up to December 2014,
were identiﬁed through theatre registers. Patient demographics, follow-up
appointments, and the use of imaging were recorded from patient
databases.
Result: 77 patients were identiﬁed of whom 42 (54.5%) were allocated a
follow-up clinic appointment. Of these, 18 (43%) were discharged after 1
appointment, and only 5 underwent long-term follow-up. The non-
attendance (DNA) rate remained high for all offered appointments (39.7 %),
with an estimated cost of £1633 to the department. Median time from I&D
to follow-up was 45 days (IQR 35e64). 10 patients had an episode of
recurrence, with 80% receiving MRI. Median time to recurrence was 38
days (IQR 16.75e99).
Conclusion: I&D successfully managed 87.1% of patients. Follow-up
practice was variable and there were high DNA rates. Recurrence tended to
occur before appointed follow-up. We recommend a telephone follow-up
policy at 4 weeks, followed by selective clinics to reduce DNA rates and
save resources.http://dx.doi.org/10.1016/j.ijsu.2016.08.154
0668: RANDOM COLONIC BIOPSIES FOR CHRONIC DIARRHOEA e A
NUMBERS NEEDED TO INVESTIGATE APPROACH
A. Shaw*, J. Hall, S. Ravi. Blackpool Victoria Hospital, Blackpool, UK.
Introduction: Current guidelines suggest that random colonic biopsies be
performed on macroscopically normal mucosa in patients undergoing
diagnostic colonoscopy for chronic diarrhoea. We aim to determine the
clinical beneﬁt and economic outcomes of diagnosing microscopic colitis
at a large District General Hospital.
Method: A retrospective analysis of a prospective database was per-
formed. All patients from January to February 2014 who underwent
diagnostic colonoscopy for chronic diarrhoea were included. Endoscopic
and histological data was correlated accordingly.
Result: 100 patients underwent colonoscopy. 87 had macroscopically
normal mucosa and subsequent biopsies. Microscopic colitis was histo-
logically conﬁrmed in eight patients (9.19%). Only one patient (1.15%)
required active treatment (cholestyramine). Cost analysis indicates pro-
cessing one sample area of random biopsies costs £48.00. On average 3
separate sample areas were taken per patient. Estimated cost to the Trust
during this time period was £14,400.
Conclusion: The Number Needed to Investigate for this sample is 87.
Taking random colonic biopsies are not without risk to the patient, have a
low diagnostic yield and signiﬁcant cost to the Trust (estimated £90k p.a.).
We therefore suggest that there's no overall beneﬁt in performing random
biopsies in this cohort of patients. Further research is required to deter-
mine which cohort beneﬁts.http://dx.doi.org/10.1016/j.ijsu.2016.08.155
